Precise execution

MC Services is...

Client News

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

read more

MC Services at analytica in Munich on April 03, 2014 (FINANCE DAY)

MC Services, the international Investor Relations and Public Relations Company, hosted a booth at this year’s analytica meeting, the leading trade fair for modern laboratory technology and biotechnology. Our focus this year was on the FINANCE DAY on April 03, 2014, in which also some of our clients participated in panel sessions.

read more

MC Services one of the main sponsors of the 7th DVFA Life Science Conference 2014

This year MC Services acted as one of the main sponsors of the 7th DVFA Life Science Conference, which took place in Frankfurt on May 07, 2014. Over recent years the DVFA Life Science Conference has become a highly valued platform to discuss new innovative technologies, therapies and products with financial market participants.

The conference focused on innovative treatment strategies for cancer, an area where MC Services’ clients have taken leading roles.

read more



MorphoSys Receives Research Grant to Develop Novel Therapeutic Antibodies Targeting GPCRs


Transgene Reports Financial Results for First Six Months of 2014 and Provides Update on TG4010


SuppreMol's clinical data in SLE for its lead product SM101 accepted for presentation at the 2014 ACR/ARHP Annual Meeting in Boston 


Poxel Raises EUR10 Million from New Investors to Progress Clinical Development of Two Novel Type 2 Diabetes Therapies


ERYTECH business update and financial results for the first half of 2014


Abdelghani Omari appointed as new Chief Financial Officer at PAION AG


Edmond de Rothschild Investment Partners sells its participation in Sapiens Steering Brain Stimulation, developer of deep brain stimulation solutions to Medtronic


Edmond de Rothschild Investment Partners sells its position in Covagen AG to Janssen Affiliate Cilag GmbH International, a Johnson & Johnson company


MorphoSys and Emergent BioSolutions Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414


MagForce AG announces positive results of 2014 Annual General Meeting